Skip to main content

Veterinary Drugs Compounding Market is Estimated to Witness High Growth

Veterinary Drugs Compounding Market

Veterinary drugs compounding refers to the process of combining, mixing, or altering ingredients to create a prescription drug tailored to an individual patient's needs. Veterinary drugs compounding provides customized formulations of FDA approved medications that are not commercially available for pets, livestock or other animals. This allows veterinarians to treat specialized medical conditions or administer medicines in an alternative form such as topical creams or flavored liquids that may be more suitable for animal patients.

The global Veterinary Drugs Compounding Market is estimated to be valued at US$ 1512.63 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The opportunity of rising pet ownership across the world is driving the veterinary drugs compounding market. People are increasingly adopting pets for companionship which is raising the demand for specialized veterinary care. According to the American Pet Products Association, the total number of pets in the US increased from 78.2 million households in 1998 to 90.5 million households in 2019. Growing bonding with pets is motivating owners to offer the best healthcare including customized medication for their animals. Veterinary drug compounding provides solutions for diseases and conditions that off-the-shelf drugs may not adequately address, fulfilling the rising need for individualized treatment of pets. This presents lucrative prospects for compounding pharmacies and drug manufacturers in the veterinary drugs compounding market.

Porter's Analysis

Threat of new entrants: The threat of new entrants is moderate. Developing new veterinary drugs involves huge capital investments and lengthy research and development procedures. There are stringent government approvals needed as well which acts as a barrier.

Bargaining power of buyers: The bargaining power of buyers is high. There is a presence of large retailers and institutional buyers who negotiate for competitive prices. Buyers can easily switch to alternative products.

Bargaining power of suppliers: The bargaining power of suppliers is moderate. There are many suppliers for raw materials used in veterinary drugs compounding. However, suppliers of active pharmaceutical ingredients have some control over pricing.

Threat of new substitutes: The threat of new substitutes is low as veterinary drugs have few alternatives to treat animal health issues. New drug delivery technologies can pose a threat.

Competitive rivalry: The competition is high among existing players.

SWOT Analysis

Strengths: Growing pet ownership, rising animal healthcare expenditure, increasing veterinary services

Weaknesses: Stringent regulations, supply chain challenges, reliance on seasonality

Opportunities: Untapped rural markets, growth in developing nations, new product innovations

Threats: Patent expiries, pricing pressures, substitution threat

Key Takeaways

The Global Veterinary Drugs Compounding Market Demand is expected to witness high growth during the forecast period of 2024 to 2031. Rapid urbanization and rising disposable incomes in developing regions are driving pet ownership. The global Veterinary Drugs Compounding Market is estimated to be valued at US$ 1512.63 Mn in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031.

The North American region currently dominates the market owing to high spending on animal health. Regional analysis shows that Asia Pacific is expected to grow at the fastest pace due to rising animal welfare standards and increasing meat consumption in China and India.

Key players operating in the Veterinary Drugs Compounding market are BASF SE, Huntsman Corporation, The Dow Chemical Company, 3M Company, DuPont, Aditya Birla Chemicals Ltd (Thailand), Momentive Specialty Chemicals Inc, Nan Ya Plastics Corporation, Kukdo Chemical Ltd., and NAMA Chemicals. These players are focused on product innovations and expanding to emerging markets.

Explore more information on this topic, Please visit -

https://www.ukwebwire.com/veterinary-drugs-compounding-market-growth-and-outlook-analysis/ 

Explore more trending article related this topic -

https://www.insightprobing.com/cancer-biomarkers-market-share-and-demand-analysis-2/ 

Comments

Popular posts from this blog

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...